A national survey shows how GLP-1associated weight loss is driving facial volume loss, laxity, and wrinklesand why fillers and neuromodulators anchor treatment for this growing patient group
Duntas LH, Papanastasiou L, Mantzou E, Koutras DA (1999) Incidence of sideropenia and effects of iron repletion treatment in women with subclinical hypothyroidism
See our medical disclaimer for full details
In this study, we found that the protein level of medium-chain acyl-CoA dehydrogenase that catalyzes the initial step of mitochondrial fatty acid -oxidation was down-regulated in expression by riboflavin deficiency
Drug Metab., 12, 667678, 2011
The 'Research Use Only' Disclaimer In Australia, peptides like BPC-157 are not approved by the Therapeutic Goods Administration (TGA) for human use